Catalyst Wire Dossier Catalyst Wire Dossier

Clarinex

desloratadine · Merck & Co.
Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for Clarinex, covering 2006-12-14 to 2024-08-15. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR)(Study P04053)(COMPLETED) [Phase 4]

See pricing